Bio-Rad witnesses first-quarter top-line decline in its Life Science segment, primarily due to challenges in the academic research market....
Zacks Investment Research - 5/2/2025 9:00:41 AM
More News for BIO
Stock Analysis for BIO
Related Stocks: